Nukkleus Operating Cycle from 2010 to 2026

NUKK Stock  USD 3.81  0.44  10.35%   
Nukkleus Operating Cycle yearly trend continues to be quite stable with very little volatility. The value of Operating Cycle is projected to decrease to 2.36. From the period between 2010 and 2026, Nukkleus, Operating Cycle regression line of its data series had standard deviation of  21.95 and standard deviation of  21.95. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
2.49
Current Value
2.36
Quarterly Volatility
21.94558744
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nukkleus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nukkleus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.1 K, Selling General Administrative of 10.4 M or Selling And Marketing Expenses of 48.6 K, as well as many indicators such as Price To Sales Ratio of 0.74, Dividend Yield of 6.0E-4 or Days Sales Outstanding of 2.36. Nukkleus financial statements analysis is a perfect complement when working with Nukkleus Valuation or Volatility modules.
  
Build AI portfolio with Nukkleus Stock
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.

Latest Nukkleus' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Nukkleus over the last few years. It is Nukkleus' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nukkleus' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Very volatile
   Operating Cycle   
       Timeline  

Nukkleus Operating Cycle Regression Statistics

Arithmetic Mean20.23
Geometric Mean9.61
Coefficient Of Variation108.48
Mean Deviation19.95
Median4.56
Standard Deviation21.95
Sample Variance481.61
Range48.4759
R-Value0.06
Mean Square Error511.75
R-Squared0
Significance0.81
Slope0.27
Total Sum of Squares7,706

Nukkleus Operating Cycle History

2026 2.36
2025 2.49
2023 2.16
2022 37.77
2021 16.39
2016 50.64

About Nukkleus Financial Statements

Nukkleus investors utilize fundamental indicators, such as Operating Cycle, to predict how Nukkleus Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 2.49  2.36 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.93)
Revenue Per Share
3.422
Quarterly Revenue Growth
(0.95)
Return On Assets
(3.97)
Return On Equity
(7.42)
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.